Home Patent Forecast® Sectors Log In   Sign Up   Free Trial   Support   Contact   Pricing  
How it works Patent Forecast® Sectors Pricing Insights
Menu
Enjoy your FREE PREVIEW which shows only 2020 data and 25 documents. For full access, try it free at any time.        

Z-ARCHIVE-Cannabis

Search All Patents in Z-ARCHIVE-Cannabis


Patent US10765658


Issued 2020-09-08

Oral Compositions Delivering Therapeutically Effective Amounts Of Cannabinoids

Oral compositions provide delivery of cannabinoids to a subject. The oral compare chewable, fast- or slow-dissolving once placed in the mouth of a subject.


Classification


Much More than Average Length Specification


View the Patent Matrix® Diagram to Explore the Claim Relationships

USPTO Full Text Publication >

3 Independent Claims

  • Independent Claim 1. A composition consisting of: about 0.1% to about 20% by weight hemp oil extract, about 35% to about 80% by weight of a sugar alcohol, or a blend of sugar alcohols, about1% to about 20% by weight of flavoring, about 0.1% to about 10% by weight of tableting lubricants and powder flow agents, about 0.01% to about 2% by weight of intensive sweeteners, and about 5% to about 25% of a gum base, based on the total weight of thecomposition.

  • Independent Claim 4. A composition for treating a disease or disorder associated with abnormal mitogen-activated protein (MAP) kinase activity or levels wherein the composition comprises hemp oil, sugar alcohol, a blend of sugar alcohols, a gum base, orcombinations thereof, wherein the composition, based on the total weight of the composition, comprises: about 0.1% to about 20% by weight hemp oil extract, about 35% to about 80% by weight of a sugar alcohol, or a blend of sugar alcohols, and about 5% toabout 25% of a gum base.

  • Independent Claim 7. A method of treating a disease or disorder associated with abnormal or increased mitogen-activated protein (MAP) kinase activity or levels in a subject, comprising: administering to a subject in need thereof, a gum-based composition forchewing, the composition consisting of: about 0.1% to about 20% by weight hemp oil extract, about 35% to about 80% by weight of a sugar alcohol, or a blend of sugar alcohols, about 1% to about 20% by weight of flavoring, about 0.1% to about 10% by weightof tableting lubricants and powder flow agents, about 0.01% to about 2% by weight of intensive sweeteners, and about 5% to about 25% of a gum base, based on the total weight of the composition, wherein the disease or disorder associated with abnormal orincreased mitogen-activated protein (MAP) kinase activity or levels in the subject is selected from the group consisting of a neuroinflammatory disease or disorder, migraines, epilepsy, neuropathic pain, general pain, joint pain, head trauma, orcombinations thereof.